Ads
related to: new kidney drug for cats
Search results
Results From The WOW.Com Content Network
Molidustat is indicated for the control of nonregenerative anemia associated with chronic kidney disease in cats. [1] [5] The US Food and Drug Administration (FDA) conditionally approved it in May 2023. [5] The reasonable expectation of effectiveness of Molidustat was evaluated in a study conducted in two phases. [5]
The injectable version is also licensed for preventing and treating acute vomiting in cats. [9] [5] [10] [11] Maropitant is effective in treating vomiting from a variety of causes, including gastroenteritis, chemotherapy, and kidney failure; [12] [13] when given beforehand, it can prevent vomiting caused by using an opioid as a premedication.
Cats are carnivores. The kidney is a vital organ with a variety of tasks. It plays an important role in maintaining the water, electrolyte and acid-base balance, in the excretion of toxic metabolic degradation products such as urea and in the recovery of valuable substances such as glucose, amino acids, peptides and minerals initially filtered out of the blood during ultrafiltration in the ...
For premium support please call: 800-290-4726 more ways to reach us
Capromorelin, sold under the brand names, Entyce and Elura, is a medication used for the management of weight loss in cats and dogs. [5] [6] Capromorelin is a ghrelin receptor agonist known to increase appetite and weight gain. [2] Capromorelin was developed by Pfizer. [7] [8] Capromorelin was approved for veterinary use in the United States in ...
It adds that cats have a low tolerance for NSAIDs. [49] [50] Also, in another scientific journal there is talk of research according to which cats that received meloxicam had greater proteinuria at 6 months than cats that received placebo. It was concluded that meloxicam should be used with caution in cats with chronic kidney disease. [51]
Ad
related to: new kidney drug for cats